AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2024-12-10T00:00:16.418134Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -2.08631M | -2.53533M | -0.57885M | -1.16538M | -0.83551M |
| Minority interest | - | - | - | - | - |
| Net income | -2.08631M | -2.53533M | -0.57885M | -1.16538M | 0.82M |
| Selling general administrative | 1.09M | 1.89M | 1.81M | 1.77M | 1.67M |
| Selling and marketing expenses | - | 0.75M | 0.86M | 0.92M | 1.00M |
| Gross profit | 0.68M | 1.20M | 2.47M | 2.82M | 2.19M |
| Reconciled depreciation | 0.47M | 0.58M | 0.52M | 0.46M | 0.29M |
| Ebit | -1.78540M | -4.05656M | -3.04315M | -2.88931M | -2.48994M |
| Ebitda | -1.51600M | -3.47663M | -2.52553M | -2.42468M | -2.20101M |
| Depreciation and amortization | 0.27M | 0.58M | 0.52M | 0.46M | 0.29M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -1.78540M | -1.88125M | -0.56615M | -1.15743M | -2.48994M |
| Other operating expenses | 2.45M | 2.83M | 3.12M | 3.13M | 6.25M |
| Interest expense | 0.30M | 0.13M | 0.01M | 0.01M | 0.01M |
| Tax provision | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Interest income | 0.30M | 0.00001M | 0.00054M | 0.01M | 0.00524M |
| Net interest income | -0.30091M | -0.13443M | -0.01269M | -0.01015M | 0.00524M |
| Extraordinary items | -1.56143M | -0.51965M | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | - | -0.44550M | -0.50493M | -0.45668M | -1.65444M |
| Total revenue | 0.69M | 2.85M | 4.34M | 4.93M | 3.76M |
| Total operating expenses | 2.46M | 5.26M | 5.51M | 5.71M | 4.68M |
| Cost of revenue | 0.01M | 1.65M | 1.87M | 2.11M | 1.57M |
| Total other income expense net | -0.30091M | 1.08M | 1.96M | 1.27M | 1.65M |
| Discontinued operations | -1.56143M | -0.51965M | -0.51965M | -0.51965M | - |
| Net income from continuing ops | -2.08631M | -2.53533M | -0.57885M | -1.16538M | -0.83551M |
| Net income applicable to common shares | -3.64774M | -2.53533M | -0.57885M | -1.16538M | -0.83551M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 2.91M | 5.61M | 6.34M | 6.85M | 6.79M |
| Intangible assets | 0.40M | 0.54M | 0.71M | 0.18M | 0.21M |
| Earning assets | - | - | - | - | - |
| Other current assets | 0.94M | 0.13M | 0.16M | 0.08M | 0.14M |
| Total liab | 4.41M | 3.48M | 1.77M | 2.30M | 1.13M |
| Total stockholder equity | -1.49908M | 2.13M | 4.57M | 4.54M | 5.67M |
| Deferred long term liab | - | 0.04M | 0.06M | - | - |
| Other current liab | 0.06M | 0.92M | 0.70M | 0.67M | 0.32M |
| Common stock | 15.37M | 15.37M | 15.37M | 14.88M | 14.87M |
| Capital stock | 15.37M | 15.37M | 15.37M | 14.88M | 14.87M |
| Retained earnings | -17.74012M | -14.09238M | -11.55705M | -10.97821M | -9.81283M |
| Other liab | 0.02M | 0.03M | 0.08M | 0.07M | 0.06M |
| Good will | - | - | - | - | - |
| Other assets | 0.00000M | 0.14M | 0.17M | 0.11M | 0.10M |
| Cash | 0.00141M | 0.21M | 0.36M | 0.76M | 1.08M |
| Cash and equivalents | 0.00067M | 0.21M | 0.36M | 0.76M | 1.08M |
| Total current liabilities | 1.71M | 1.58M | 1.60M | 2.23M | 1.06M |
| Current deferred revenue | 0.68M | -0.46266M | -0.27180M | 0.33M | 0.11M |
| Net debt | 3.13M | 2.13M | -0.00810M | -0.58905M | -0.99203M |
| Short term debt | 0.45M | 0.46M | 0.27M | 0.17M | 0.08M |
| Short long term debt | 0.31M | 0.33M | 0.21M | 0.00794M | 0.08M |
| Short long term debt total | 3.13M | 2.33M | 0.36M | 0.17M | 0.08M |
| Other stockholder equity | 0.87M | -1.27385M | -3.80918M | -3.89758M | 5.11M |
| Property plant equipment | 0.32M | 0.58M | 0.70M | 1.06M | 0.97M |
| Total current assets | 2.20M | 4.38M | 4.82M | 5.50M | 5.51M |
| Long term investments | - | 0.11M | 0.11M | 0.11M | 0.10M |
| Net tangible assets | -1.89985M | 1.63M | 3.93M | 4.36M | 5.46M |
| Short term investments | - | - | - | - | - |
| Net receivables | 1.14M | 1.20M | 1.27M | 1.43M | 1.16M |
| Long term debt | 2.55M | 1.87M | 0.08M | - | - |
| Inventory | 0.00000M | 2.85M | 3.02M | 3.23M | 3.13M |
| Accounts payable | 0.52M | 0.66M | 0.90M | 1.06M | 0.55M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 0.87M | 0.86M | 0.76M | 0.65M | 0.62M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 14.88M | 14.87M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -0.71680M | -1.08439M | -1.35008M | -1.23572M | 1.29M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 0.72M | 1.23M | 1.52M | 1.34M | 1.29M |
| Capital lease obligations | 0.27M | 0.14M | 0.06M | 0.16M | - |
| Long term debt total | 2.68M | 1.87M | 0.08M | 0.00000M | 0.00000M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | 0.07M | -0.10505M | -0.11649M | -0.14056M | -0.04946M |
| Change to liabilities | 0.13M | -0.29218M | -0.76121M | 1.12M | -0.00590M |
| Total cashflows from investing activities | 0.07M | -0.10505M | -0.11649M | -0.14056M | -0.04946M |
| Net borrowings | 0.43M | 1.75M | -0.16213M | -0.22305M | -0.03617M |
| Total cash from financing activities | 0.43M | 1.81M | 0.09M | -0.00178M | 0.57M |
| Change to operating activities | 0.03M | 0.06M | -0.04224M | 0.11M | 0.00455M |
| Net income | -3.64774M | -2.53533M | -0.57885M | -1.16538M | -0.83551M |
| Change in cash | -0.26963M | -0.15689M | -0.39237M | -0.32083M | -0.53851M |
| Begin period cash flow | 0.21M | 0.36M | 0.76M | 1.08M | 1.61M |
| End period cash flow | -0.06330M | 0.21M | 0.36M | 0.76M | 1.08M |
| Total cash from operating activities | -0.77550M | -1.86247M | -0.36197M | -0.17850M | -1.05788M |
| Issuance of capital stock | - | - | 0.00833M | 0.01M | - |
| Depreciation | 0.44M | 0.53M | 0.48M | 0.44M | 0.29M |
| Other cashflows from investing activities | 0.11M | 0.11M | 0.11M | 0.11M | 0.00000M |
| Dividends paid | - | - | 0.25M | 0.00211M | - |
| Change to inventory | 0.08M | -0.35345M | 0.21M | -0.10630M | -0.09758M |
| Change to account receivables | 0.06M | 0.08M | 0.16M | -0.26979M | -0.13373M |
| Sale purchase of stock | - | 0.00000M | -0.00211M | -0.00211M | 0.00000M |
| Other cashflows from financing activities | 0.79M | 1.91M | 0.58M | 0.06M | 0.59M |
| Change to netincome | 2.11M | 0.60M | 0.13M | -0.33410M | -0.27864M |
| Capital expenditures | 0.03M | 0.11M | 0.12M | 0.14M | 0.05M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 0.14M | -0.27701M | 0.37M | -0.37609M | 0.00390M |
| Stock based compensation | 0.02M | 0.09M | 0.12M | 0.03M | - |
| Other non cash items | 2.44M | 0.14M | -0.26309M | 0.55M | 0.55M |
| Free cash flow | -0.80863M | -1.96751M | -0.47846M | -0.31906M | -0.04946M |
Sector: Healthcare Industry: Medical Devices
| Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AMT Allegra Medical Technologies Limited |
- -% | - | - | - | 5.02 | 5.52 | 1.73 | -1.9669 |
| COH Cochlear Ltd |
10.33 3.79% | 283.18 | 47.77 | 38.76 | 7.65 | 9.44 | 7.58 | 29.28 |
| PNV Polynovo Ltd |
-0.005 0.42% | 1.18 | 126.50 | 147.06 | 7.56 | 11.58 | 7.45 | 93.59 |
| IMR Imricor Medical Systems Inc |
-0.028 1.73% | 1.59 | - | - | 564.46 | 3.97 | 374.91 | -2.6027 |
| EBR Ebr Systems Inc CDR |
-0.02 1.82% | 1.08 | - | - | - | 19.90 | -3.6785 |
Allegra Medical Technologies Limited designs, sells, and distributes medical device products in Australia. The company provides adult and adolescent clavicle fixation systems; a range of symmetrical and asymmetrical offsets for shoulder; and StripEase, ChiroKlip, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads for heads. It also offers reconstruction prosthesis, modular tumor and revision system, partial pelvis replacement, standard C cementless stem, revision cup, hip acetabular cup system, IP acetabular cup, ceramic prosthesis heads, and CoCrMo prosthesis heads, as well as cemented femoral stem, unipolar head, and cup resector; ActiveKnee, a total knee replacement prosthesis and knee distal first instruments, femoral condyle, nanofracture, arthrodesis nail, modular knee, rotational and hinge knee, and uni knee; and foot and ankle products, such as total ankle replacement systems, DF toe, A-curve handles, screws, activ fuse, and plating system. In addition, the company provides sawblades and kirschner wires and pins. Further, it offers NanoFx, a solution for microfracture procedure; and instrument sets, including post-surgery rehabilitation, shoulder surgery, direct anterior approach, PCL protector, and revision surgery instrument. The company was formerly known as Allegra Orthopaedics Limited and changed its name to Allegra Medical Technologies Limited in November 2023. Allegra Medical Technologies Limited was incorporated in 1994 and is based in Lane Cove West, Australia.
18-20 Orion Road, Lane Cove West, NSW, Australia, 2066
| Name | Title | Year Born |
|---|---|---|
| Ms. Jennifer Swain | Chief Exec. Officer | NA |
| Mr. Vincent Wang | Fin. Mang. | NA |
| Mr. Robert Bell | Head of Technology & Innovation | NA |
| Ms. Robyn Slaughter | Company Sec. | NA |
| Ms. Jennifer Swain | Chief Executive Officer | NA |
| Mr. Vincent Wang | Finance Manager | NA |
| Ms. Ellen Newsom | Head of Technology & Innovation | NA |
| Ms. Robyn Slaughter | Company Secretary | NA |
| Ms. Jennifer Swain | Chief Executive Officer | NA |
| Mr. Vincent Wang | Finance Manager | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...